China green lights Eli Lilly oral obesity treatment with orforglipron

The News International12 Nov 2026, 13:12 PKTvia NewsData.io

China green lights Eli Lilly oral obesity treatment with orforglipronChina has approved orforglipron, Eli Lilly’s once-daily oral medication for weight management, marking another milestone in the growing market for GLP-1-based obesity treatments. The country’s drug regulator announced the...

Read the full story on The News International

Headline and summary provided via NewsData.io. The full article and its copyright belong to the original publisher.